Cell & Gene Therapies: US FDA Broadens Acceptable Use of RWD, Registries and AI

 
• By Manas Mishra
  
US FDA encourages the use of digital health tools in new guidance to sponsors of CGT trials. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies